A tertiary care cancer center experience of the 2007 outbreak of serratia marcescens bloodstream infection due to prefilled syringes

Infection Control and Hospital Epidemiology

Volumn 30, Issue 12, 2009, Pages 1237-1238

  Chemaly, Roy F ^a   Rathod, Dhanesh B ^a   Raad, Issam I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SODIUM CHLORIDE;

BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BIOFILM; BLOODSTREAM INFECTION; CANCER PATIENT; EPIDEMIC; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTRAVENOUS CATHETER; LETTER; SERRATIA MARCESCENS; SYRINGE; UNITED STATES;

CANCER CARE FACILITIES; CROSS INFECTION; DISEASE OUTBREAKS; EQUIPMENT CONTAMINATION; HOSPITALS, TEACHING; HUMANS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; SYRINGES; TEXAS;

EID: 73449129027     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/648661     Document Type: Letter

References (4)

1. Su JR, Blossom DB, Chung W, et al. Epidemiologic investigation of a 2007 outbreak of Serratia marcescens bloodstream infection in Texas caused by contamination of syringes prefilled with heparin and saline. Infect Control Hosp Epidemiol 2009;30:593-595.
2. Chemaly RF, Tarrand J, Adachi J, et al. Investigation of an outbreak of Serratia marcescens bacteremia in cancer patients leading to a national recall of a second unsuspected contaminated source: time for antimicrobial lock therapy? In: Program and abstracts of the 48th Annual ICAAC/IDSA 46th Annual Meeting; October 2008; Washington, DC. Abstract K903.
3. AM2 PAT, Inc issues nationwide recall of prefilled heparin lock flush solution USP (5 mL in 12 mL syringes). Available at: http://www.fda.gov/Safety/ Recalls/ArchiveRecalls/2007/ucm112333.htm. Accessed October 20, 2009.
4. B. Braun's supplier prompts voluntary recall of all lots and all sizes of prefilled heparin and normal saline flush syringes. Available at: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2008/ucm112343.htm. Accessed October 20, 2009.